BCL2L11 and acute lymphoblastic leukemia: This is evidenced by our data showing decreased p-BIM expression and greater cell death in pevonedistat + SEL treated ALL cells, together with Co-IP experiments demonstrating that changes in the interaction between BIM and Bcl-2 or Bcl-xL correlate with cell death.